Market Value2,293,585,000
Total Holdings69
File Date2018-02-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
GWP / GW Pharmaceuticals plc
EHTH / eHealth, Inc.
CELG / Celgene Corp.
04269XAB1 / Array Biopharma Inc Bond
NKTR / Nektar Therapeutics
PCRX / Pacira BioSciences, Inc.
PETQ / PetIQ, Inc.
CNC / Centene Corporation
TDOC / Teladoc Health, Inc.
MODN / Model N, Inc.
JNCE / Jounce Therapeutics Inc
AET / Aetna, Inc.
GMED / Globus Medical, Inc.
TFX / Teleflex Incorporated
CASC / Cascadian Therapeutics, Inc.
CTMX / CytomX Therapeutics, Inc.
PBYI / Puma Biotechnology, Inc.
MDRX / Veradigm Inc.
LUMO / Lumos Pharma, Inc.
CMRX / Chimerix, Inc.
FATE / Fate Therapeutics, Inc.
AUPH / Aurinia Pharmaceuticals Inc.
WVE / Wave Life Sciences Ltd.
EPZM / Epizyme Inc
HOLX / Hologic, Inc.
ODT / Odonate Therapeutics Inc
NDRM / NeuroDerm Ltd.
SYNH / Syneos Health Inc - Class A
SGEN / Seagen Inc
SYRS / Syros Pharmaceuticals, Inc.
XNCR / Xencor, Inc.
ANAB / AnaptysBio, Inc.
MOH / Molina Healthcare, Inc.
US29266S3040 / Endologix, Inc.
BOLD / Boundless Bio, Inc.
MEDP / Medpace Holdings, Inc.
DPLO / Diplomat Pharmacy, Inc.
AZN / AstraZeneca PLC - Depositary Receipt (Common Stock)
WCG / Wellcare Health Plans, Inc.
ACRS / Aclaris Therapeutics, Inc.
HSKA / Heska Corp. (Restricted Voting)
SHPG / Shire Plc.
LHCG / LHC Group Inc
LJPC / La Jolla Pharmaceutical Co.
NITE / Capitol Series Trust - The Nightview Fund
VCRA / Vocera Communication Inc
/ Oxford Immunotec Global PLC
CSLT / Castlight Health Inc - Class B
PRQR / ProQR Therapeutics N.V.
ADVM / Adverum Biotechnologies, Inc.
ALDR / Alder BioPharmaceuticals, Inc.
VRTX / Vertex Pharmaceuticals Incorporated
IFRX / InflaRx N.V.
ASXC / Asensus Surgical, Inc.
GLYC / GlycoMimetics, Inc.
CLVS / Clovis Oncology Inc
ALGN / Align Technology, Inc.
OVID / Ovid Therapeutics Inc.
US69354M1080 / PRA Health Sciences Inc
NVTA / Invitae Corporation
HZNP / Horizon Therapeutics Plc
UHS / Universal Health Services, Inc.
AMED / Amedisys, Inc.
IRTC / iRhythm Technologies, Inc.
ARGX / argenx SE - Depositary Receipt (Common Stock)
ICUI / ICU Medical, Inc.
/ Array BioPharma, Inc.
BMRN / BioMarin Pharmaceutical Inc.
UNH / UnitedHealth Group Incorporated
FOLD / Amicus Therapeutics, Inc.
BSX / Boston Scientific Corporation
BLUE / bluebird bio, Inc.
INSM / Insmed Incorporated
CBAY / CymaBay Therapeutics, Inc.
RGNX / REGENXBIO Inc.
NBIX / Neurocrine Biosciences, Inc.
IMGN / ImmunoGen, Inc.
HUM / Humana Inc.
DCPH / Deciphera Pharmaceuticals, Inc.
ABT / Abbott Laboratories
PEN / Penumbra, Inc.
LIVN / LivaNova PLC
CTLT / Catalent, Inc.
ATRA / Atara Biotherapeutics, Inc.